Become a Member
Become a Member
Contact Us
Contact Us

Non Invasive Treatment

Devices and procedures marketed for hair loss treatment have become increasingly popular among consumers seeking alternatives or additions to conventional medical therapies. These include low-level light therapy (LLLT), microneedling and technologies designed to enhance the delivery of topical preparations, such as TransEpidermal Delivery (TED).

Although these approaches are frequently promoted as innovative solutions for thinning hair, their clinical evidence, potential benefits and safety profiles vary considerably. Some have demonstrated modest improvements under controlled study conditions, while others remain inadequately evaluated or are supported primarily by preliminary research and promotional claims.

Importantly, not every treatment in this category is truly non-invasive. Microneedling intentionally punctures the scalp and is more accurately described as a minimally invasive procedure. Consumers should understand these distinctions and recognize that a procedure does not become inherently safe or effective simply because it is marketed as nonsurgical.

The popularity of a hair loss treatment should never be confused with scientific validation. Medical practices and manufacturers increasingly promote devices and procedures using claims about follicular stimulation, improved scalp circulation, enhanced absorption and hair regrowth. However, a proposed biological mechanism does not establish that a treatment produces meaningful, lasting clinical results.

Low-level light therapy has demonstrated modest benefits in some controlled studies, but results cannot automatically be generalized to every commercially available device. Microneedling raises additional concerns about inflammation, infection, scarring and the consequences of repeatedly disrupting the scalp barrier. Technologies such as TED introduce separate questions about the effectiveness, safety and consistency of the topical preparations being delivered.

The American Hair Loss Association evaluates these approaches according to the quality of the supporting evidence, reproducibility of outcomes, potential risks and their value relative to established medical treatments. Inclusion in this section should not be interpreted as an AHLA endorsement or recommendation. Our objective is to help consumers distinguish credible findings from unproven claims and make more informed treatment decisions.

Low Level Laser Light Therapy (LLLT) for Hair Loss

Low-level light therapy uses red or near-infrared light delivered through devices such as laser caps, helmets and combs. Certain devices have produced measurable improvements in hair density in controlled clinical trials involving androgenetic alopecia, although the degree of visible cosmetic benefit varies and results from one device cannot automatically be applied to another.

Differences in wavelength, delivered energy, treatment schedules, device design and study quality make it difficult to generalize findings across the category. FDA clearance should not be confused with proof of substantial clinical effectiveness or interpreted as an endorsement of every device marketed for hair growth. The AHLA encourages consumers to evaluate the evidence supporting a specific product, maintain realistic expectations and understand the limitations of light-based treatments.

Used for: Male Pattern Baldness, Female Pattern Baldness

Learn More

Microneedling for Hair Loss

Microneedling involves repeatedly puncturing the scalp with small needles using a roller, stamp or motorized device. Although several clinical studies have reported improved hair growth, particularly when microneedling is combined with topical minoxidil, treatment protocols vary considerably and the long-term consequences of repeated scalp injury remain inadequately studied.

Potential complications include inflammation, infection, scarring and possible follicular injury. Repeated disruption of the scalp barrier also raises concerns about the absorption and tolerability of topical medications, especially formulations containing alcohol or other potentially irritating ingredients. The American Hair Loss Association does not recommend microneedling as a routine treatment for androgenetic alopecia, particularly unsupervised home procedures or the application of alcohol-based topical formulations to freshly treated skin.

Used for: Male Pattern Baldness, Female Pattern Baldness

Learn More

TransEpidermal Delivery (TED)

TransEpidermal Delivery (TED) uses acoustic or ultrasound-based technology designed to enhance the penetration of topical preparations through the scalp without needles. Commercial systems are frequently promoted in combination with proprietary formulations containing ingredients claimed to support follicular activity and hair growth.

However, improving the delivery of a substance does not establish that the substance itself can effectively treat androgenetic alopecia. The clinical evidence supporting TED-based hair restoration remains limited, and the effectiveness and safety of individual protocols may depend on the formulations, concentrations and treatment methods used. The AHLA considers this an area requiring further investigation rather than an established hair loss treatment. Consumers should be cautious about claims of significant regrowth that are not supported by appropriately controlled clinical studies.

Used for: Male Pattern Baldness, Female Pattern Baldness

Learn More

Featured Articles

Hair Loss Research, Treatment Advances, Hair Transplant Surgery and Consumer Protection

All Articles

Education - 

Research - 

Commitment

Become a Member
Contact Us